Firms
Sanofi Ventures
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Lifordi Immunotherapeutics$— · 2025-11-19Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
bluebird bio$60M · 2012-07-25
Rome$72M · Unknown date
Areteia Therapeutics$75M · Unknown date
Bain CapitalAbcuro, Inc.$200M · 2025-02-12
AdvanCell$315M · Unknown date
Abcuro$200M · Unknown date
Areteia Therapeutics$75M · Unknown date
Alexandria Venture Investments
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Rome$72M · Unknown date
Mass General Brigham Ventures
Abcuro, Inc.$200M · 2025-02-12
Abcuro$200M · Unknown date
Rome$72M · Unknown date
Bpifrance
- Eligo$30M · 2023-12-05
Eligo Bioscience$30M · 2023-12-05
Casdin Capital
Character Biosciences$93M · Unknown date
Rome$72M · Unknown date
Catalio Capital Management
Character Biosciences$93M · Unknown date
AdvanCell$315M · Unknown date
Emerson Collective
Formation$372M · 2024-11-06
Formation Bio$372M · 2024-06-26
FPV Ventures
Formation$372M · 2024-11-06
Formation Bio$372M · 2024-06-26
Khosla Ventures- Eligo$30M · 2023-12-05
Eligo Bioscience$30M · 2023-12-05
Logos Capital
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Pontifax
Abcuro, Inc.$200M · 2025-02-12
Abcuro$200M · Unknown date
Sequoia
Formation$372M · 2024-11-06
Formation Bio$372M · 2024-06-26
Seventure Partners
- Eligo$30M · 2023-12-05
Eligo Bioscience$30M · 2023-12-05
Thrive Capital
Formation$372M · 2024-11-06
Formation Bio$372M · 2024-06-26
Alpha Wave Global
AdvanCell$315M · Unknown date
Alphabet Inc.
Areteia Therapeutics$75M · Unknown date
AMD Ventures
Lifordi Immunotherapeutics$— · 2025-11-19
aMoon
Character Biosciences$93M · Unknown date
Andreessen Horowitz
Formation$372M · 2024-11-06
Atlas Venture
Lifordi Immunotherapeutics$— · 2025-11-19
Blue Owl Healthcare Opportunities
Mirador Tx$400M · 2024-03-21
Bowery Capital
Zag Bio$80M · 2025-10-28
Cormorant Asset Management
Abcuro$200M · Unknown date
Deerfield
bluebird bio$60M · 2012-07-25
Eventide Asset Management
AdvanCell$315M · Unknown date
Farallon Capital Management
Mirador Therapeutics$250M · 2025
Fidelity Management & Research Company
Mirador Tx$400M · 2024-03-21
Forbion
bluebird bio$60M · 2012-07-25
GV
Areteia Therapeutics$75M · Unknown date
Innovation Endeavors
Character Biosciences$93M · Unknown date
Koch Disruptive Technologies
Zag Bio$80M · 2025-10-28
Lightspeed
Zag Bio$80M · 2025-10-28
Maverick Ventures
Areteia Therapeutics$75M · Unknown date
Mirae Asset
Rome$72M · Unknown date
Mission BioCapital
Zag Bio$80M · 2025-10-28
New Enterprise Associates
Abcuro, Inc.$200M · 2025-02-12
New Leaf Venture Partners
Abcuro, Inc.$200M · 2025-02-12
Octopus Ventures
Medisafe$30M · 2021-02-25
Qualcomm Ventures
Medisafe$30M · 2021-02-25
ReGen Ventures
Zag Bio$80M · 2025-10-28
S32
Character Biosciences$93M · Unknown date
Samir Kaul
Eligo Bioscience$30M · 2023-12-05
Samsara BioCapital
Abcuro$200M · Unknown date
SV Angel
Formation Bio$372M · 2024-06-26
T. Rowe Price
AdvanCell$315M · Unknown date
Third Rock Ventures
bluebird bio$60M · 2012-07-25
Triventures
Medisafe$30M · 2021-02-25
Vesper Holding
- Eligo$30M · 2023-12-05
Viking Global Investors
Areteia Therapeutics$75M · Unknown date
Y Combinator
Rome$72M · Unknown date

